CA2578078A1 - Sensor - Google Patents
Sensor Download PDFInfo
- Publication number
- CA2578078A1 CA2578078A1 CA002578078A CA2578078A CA2578078A1 CA 2578078 A1 CA2578078 A1 CA 2578078A1 CA 002578078 A CA002578078 A CA 002578078A CA 2578078 A CA2578078 A CA 2578078A CA 2578078 A1 CA2578078 A1 CA 2578078A1
- Authority
- CA
- Canada
- Prior art keywords
- sensor
- patient
- pco2
- skin
- sensing device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims abstract description 34
- 238000005259 measurement Methods 0.000 claims abstract description 23
- 229910002092 carbon dioxide Inorganic materials 0.000 claims abstract description 18
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 12
- 239000001301 oxygen Substances 0.000 claims abstract description 12
- 239000001569 carbon dioxide Substances 0.000 claims abstract description 9
- 230000036961 partial effect Effects 0.000 claims abstract description 8
- 230000036760 body temperature Effects 0.000 claims abstract description 5
- 239000012528 membrane Substances 0.000 claims description 46
- 239000007788 liquid Substances 0.000 claims description 40
- 238000003780 insertion Methods 0.000 claims description 37
- 230000037431 insertion Effects 0.000 claims description 37
- 239000000853 adhesive Substances 0.000 claims description 22
- 230000001070 adhesive effect Effects 0.000 claims description 16
- 210000001519 tissue Anatomy 0.000 description 24
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical group CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000546 pharmaceutical excipient Substances 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 10
- 206010040047 Sepsis Diseases 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000004033 plastic Substances 0.000 description 9
- 229920003023 plastic Polymers 0.000 description 9
- 238000012544 monitoring process Methods 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 210000003205 muscle Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 238000001514 detection method Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 238000006213 oxygenation reaction Methods 0.000 description 6
- 239000011505 plaster Substances 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 239000010931 gold Substances 0.000 description 4
- 229910052737 gold Inorganic materials 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 238000003860 storage Methods 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 3
- 229920000271 Kevlar® Polymers 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 239000000645 desinfectant Substances 0.000 description 3
- -1 hydroxyl ions Chemical class 0.000 description 3
- 208000028867 ischemia Diseases 0.000 description 3
- 239000004761 kevlar Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 229920002379 silicone rubber Polymers 0.000 description 3
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 2
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 206010020591 Hypercapnia Diseases 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 239000000644 isotonic solution Substances 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000098 polyolefin Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000012935 Averaging Methods 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000005391 art glass Substances 0.000 description 1
- 230000008081 blood perfusion Effects 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000005796 circulatory shock Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005530 etching Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000000122 hyperventilation Diseases 0.000 description 1
- 230000000870 hyperventilation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000002991 molded plastic Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000003586 protic polar solvent Substances 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000005428 wave function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14542—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring blood gases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1473—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
- A61B5/412—Detecting or monitoring sepsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6801—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be attached to or worn on the body surface
- A61B5/683—Means for maintaining contact with the body
- A61B5/6832—Means for maintaining contact with the body using adhesives
- A61B5/6833—Adhesive patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6848—Needles
- A61B5/6849—Needles in combination with a needle set
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Vascular Medicine (AREA)
- Immunology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0419958A GB0419958D0 (en) | 2003-10-20 | 2004-09-08 | Sensor |
GB0419958.4 | 2004-09-08 | ||
PCT/GB2005/003461 WO2006027586A1 (en) | 2004-09-08 | 2005-09-08 | Sensor |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2578078A1 true CA2578078A1 (en) | 2006-03-16 |
Family
ID=35207357
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002578078A Abandoned CA2578078A1 (en) | 2004-09-08 | 2005-09-08 | Sensor |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1788933A1 (zh) |
JP (1) | JP2008512162A (zh) |
KR (1) | KR20070052781A (zh) |
CN (1) | CN101026996A (zh) |
AU (1) | AU2005281502A1 (zh) |
BR (1) | BRPI0514953A (zh) |
CA (1) | CA2578078A1 (zh) |
NO (1) | NO20071363L (zh) |
WO (1) | WO2006027586A1 (zh) |
Families Citing this family (77)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8802183B2 (en) | 2005-04-28 | 2014-08-12 | Proteus Digital Health, Inc. | Communication system with enhanced partial power source and method of manufacturing same |
US9198608B2 (en) | 2005-04-28 | 2015-12-01 | Proteus Digital Health, Inc. | Communication system incorporated in a container |
US8730031B2 (en) | 2005-04-28 | 2014-05-20 | Proteus Digital Health, Inc. | Communication system using an implantable device |
US8836513B2 (en) | 2006-04-28 | 2014-09-16 | Proteus Digital Health, Inc. | Communication system incorporated in an ingestible product |
US8912908B2 (en) | 2005-04-28 | 2014-12-16 | Proteus Digital Health, Inc. | Communication system with remote activation |
CN103259027A (zh) | 2005-04-28 | 2013-08-21 | 普罗透斯数字保健公司 | 药物信息*** |
US8547248B2 (en) | 2005-09-01 | 2013-10-01 | Proteus Digital Health, Inc. | Implantable zero-wire communications system |
KR101568660B1 (ko) | 2006-05-02 | 2015-11-12 | 프로테우스 디지털 헬스, 인코포레이티드 | 환자 주문형 치료법 |
ATE535057T1 (de) | 2006-10-17 | 2011-12-15 | Proteus Biomedical Inc | Niederspannungsoszillator für medizinische einrichtungen |
KR101611240B1 (ko) | 2006-10-25 | 2016-04-11 | 프로테우스 디지털 헬스, 인코포레이티드 | 복용 가능한 제어된 활성화 식별자 |
WO2008063626A2 (en) | 2006-11-20 | 2008-05-29 | Proteus Biomedical, Inc. | Active signal processing personal health signal receivers |
WO2008095183A2 (en) | 2007-02-01 | 2008-08-07 | Proteus Biomedical, Inc. | Ingestible event marker systems |
JP5614991B2 (ja) | 2007-02-14 | 2014-10-29 | プロテウス デジタル ヘルス, インコーポレイテッド | 大表面積電極を有する体内型電源 |
US9270025B2 (en) | 2007-03-09 | 2016-02-23 | Proteus Digital Health, Inc. | In-body device having deployable antenna |
EP2124725A1 (en) | 2007-03-09 | 2009-12-02 | Proteus Biomedical, Inc. | In-body device having a multi-directional transmitter |
US8540632B2 (en) | 2007-05-24 | 2013-09-24 | Proteus Digital Health, Inc. | Low profile antenna for in body device |
ES2928197T3 (es) | 2007-09-25 | 2022-11-16 | Otsuka Pharma Co Ltd | Dispositivo intracorpóreo con amplificación de señal de dipolo virtual |
EP3235491B1 (en) | 2008-03-05 | 2020-11-04 | Proteus Digital Health, Inc. | Multi-mode communication ingestible event markers and systems |
SG195535A1 (en) | 2008-07-08 | 2013-12-30 | Proteus Digital Health Inc | Ingestible event marker data framework |
CN102176862B (zh) | 2008-08-13 | 2014-10-22 | 普罗透斯数字保健公司 | 可摄入电路 |
KR101192690B1 (ko) | 2008-11-13 | 2012-10-19 | 프로테우스 디지털 헬스, 인코포레이티드 | 섭취 가능한 치료 활성화 시스템, 치료 장치 및 방법 |
AU2009324536A1 (en) | 2008-12-11 | 2011-07-14 | Proteus Digital Health, Inc. | Evaluation of gastrointestinal function using portable electroviscerography systems and methods of using the same |
TWI503101B (zh) | 2008-12-15 | 2015-10-11 | Proteus Digital Health Inc | 與身體有關的接收器及其方法 |
US9659423B2 (en) | 2008-12-15 | 2017-05-23 | Proteus Digital Health, Inc. | Personal authentication apparatus system and method |
US9439566B2 (en) | 2008-12-15 | 2016-09-13 | Proteus Digital Health, Inc. | Re-wearable wireless device |
CN102326072B (zh) * | 2008-12-22 | 2014-09-10 | 雷迪奥米特医学公司 | 平板传感器 |
JP2012514799A (ja) | 2009-01-06 | 2012-06-28 | プロテウス バイオメディカル インコーポレイテッド | 摂取に関連するバイオフィードバックおよび個別薬物療法の方法およびシステム |
CN102365084B (zh) | 2009-01-06 | 2014-04-30 | 普罗秋斯数字健康公司 | 药剂递送*** |
US9041541B2 (en) | 2010-01-28 | 2015-05-26 | Seventh Sense Biosystems, Inc. | Monitoring or feedback systems and methods |
US20110288389A9 (en) * | 2009-03-02 | 2011-11-24 | Seventh Sense Biosystems, Inc. | Oxygen sensor |
US20100256524A1 (en) | 2009-03-02 | 2010-10-07 | Seventh Sense Biosystems, Inc. | Techniques and devices associated with blood sampling |
WO2010111403A2 (en) | 2009-03-25 | 2010-09-30 | Proteus Biomedical, Inc. | Probablistic pharmacokinetic and pharmacodynamic modeling |
SG175388A1 (en) | 2009-04-28 | 2011-12-29 | Proteus Biomedical Inc | Highly reliable ingestible event markers and methods for using the same |
EP2432458A4 (en) | 2009-05-12 | 2014-02-12 | Proteus Digital Health Inc | ACCEPTABLE EVENT MARKER WITH SUGAR COMPONENT |
EP2467707A4 (en) | 2009-08-21 | 2014-12-17 | Proteus Digital Health Inc | DEVICE AND METHOD FOR MEASURING BIOLOGICAL PARAMETERS |
TWI517050B (zh) | 2009-11-04 | 2016-01-11 | 普羅托斯數位健康公司 | 供應鏈管理之系統 |
UA109424C2 (uk) | 2009-12-02 | 2015-08-25 | Фармацевтичний продукт, фармацевтична таблетка з електронним маркером і спосіб виготовлення фармацевтичної таблетки | |
WO2011094606A2 (en) | 2010-02-01 | 2011-08-04 | Proteus Biomedical, Inc. | Data gathering system |
JP6463599B2 (ja) | 2010-04-07 | 2019-02-06 | プロテウス デジタル ヘルス, インコーポレイテッド | 小型の摂取可能なデバイス |
TWI557672B (zh) | 2010-05-19 | 2016-11-11 | 波提亞斯數位康健公司 | 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置 |
CN101822859B (zh) * | 2010-06-08 | 2012-03-07 | 中国人民解放军军事医学科学院卫生装备研究所 | 低血容量休克液体复苏的闭环控制装置 |
US9125625B2 (en) | 2010-06-10 | 2015-09-08 | The Regents Of The University Of California | Textile-based printable electrodes for electrochemical sensing |
WO2011163347A2 (en) | 2010-06-23 | 2011-12-29 | Seventh Sense Biosystems, Inc. | Sampling devices and methods involving relatively little pain |
JP2013538069A (ja) | 2010-07-16 | 2013-10-10 | セブンス センス バイオシステムズ,インコーポレーテッド | 流体移動デバイスのための低圧環境 |
WO2012021801A2 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
US8808202B2 (en) | 2010-11-09 | 2014-08-19 | Seventh Sense Biosystems, Inc. | Systems and interfaces for blood sampling |
JP2014504902A (ja) | 2010-11-22 | 2014-02-27 | プロテウス デジタル ヘルス, インコーポレイテッド | 医薬品を有する摂取可能なデバイス |
US9439599B2 (en) | 2011-03-11 | 2016-09-13 | Proteus Digital Health, Inc. | Wearable personal body associated device with various physical configurations |
US20130158468A1 (en) | 2011-12-19 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving material with respect to a subject surface |
AU2012249683A1 (en) | 2011-04-29 | 2013-11-14 | Seventh Sense Biosystems, Inc. | Devices and methods for collection and/or manipulation of blood spots or other bodily fluids |
WO2012149143A1 (en) | 2011-04-29 | 2012-11-01 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving fluids |
EP3106092A3 (en) | 2011-04-29 | 2017-03-08 | Seventh Sense Biosystems, Inc. | Systems and methods for collecting fluid from a subject |
US9756874B2 (en) | 2011-07-11 | 2017-09-12 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
WO2015112603A1 (en) | 2014-01-21 | 2015-07-30 | Proteus Digital Health, Inc. | Masticable ingestible product and communication system therefor |
CA2842952C (en) | 2011-07-21 | 2019-01-08 | Proteus Digital Health, Inc. | Mobile communication device, system, and method |
US9737247B2 (en) | 2011-09-02 | 2017-08-22 | The Regents Of The University Of California | Microneedle arrays for biosensing and drug delivery |
US9235683B2 (en) | 2011-11-09 | 2016-01-12 | Proteus Digital Health, Inc. | Apparatus, system, and method for managing adherence to a regimen |
ES2967970T3 (es) | 2012-07-23 | 2024-05-06 | Otsuka Pharma Co Ltd | Técnicas para fabricar marcadores de eventos ingeribles que comprenden un componente ingerible |
MY168018A (en) | 2012-10-18 | 2018-10-11 | Proteus Biomedical Inc | Apparatus, system , and method to adaptively optimize power dissipation and broadcast power in a power source for a communication device |
TWI659994B (zh) | 2013-01-29 | 2019-05-21 | 美商普羅托斯數位健康公司 | 高度可膨脹之聚合型薄膜及包含彼之組成物 |
JP6498177B2 (ja) | 2013-03-15 | 2019-04-10 | プロテウス デジタル ヘルス, インコーポレイテッド | 本人認証装置システムおよび方法 |
WO2014144738A1 (en) | 2013-03-15 | 2014-09-18 | Proteus Digital Health, Inc. | Metal detector apparatus, system, and method |
JP6511439B2 (ja) | 2013-06-04 | 2019-05-15 | プロテウス デジタル ヘルス, インコーポレイテッド | データ収集および転帰の査定のためのシステム、装置、および方法 |
JP6532460B2 (ja) * | 2013-07-26 | 2019-06-19 | コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. | 患者モニタリングシステムに関する臨床規則及び規定のコンピュータ化及び視覚化 |
US9796576B2 (en) | 2013-08-30 | 2017-10-24 | Proteus Digital Health, Inc. | Container with electronically controlled interlock |
EP3047618B1 (en) | 2013-09-20 | 2023-11-08 | Otsuka Pharmaceutical Co., Ltd. | Methods, devices and systems for receiving and decoding a signal in the presence of noise using slices and warping |
WO2015044722A1 (en) | 2013-09-24 | 2015-04-02 | Proteus Digital Health, Inc. | Method and apparatus for use with received electromagnetic signal at a frequency not known exactly in advance |
US10084880B2 (en) | 2013-11-04 | 2018-09-25 | Proteus Digital Health, Inc. | Social media networking based on physiologic information |
US11051543B2 (en) | 2015-07-21 | 2021-07-06 | Otsuka Pharmaceutical Co. Ltd. | Alginate on adhesive bilayer laminate film |
CN108699585A (zh) * | 2016-02-23 | 2018-10-23 | 皇家飞利浦有限公司 | 用于对母乳腐坏进行原地检测的方法 |
AU2017279335B2 (en) * | 2016-06-10 | 2019-07-18 | Terumo Kabushiki Kaisha | Oxygen measurement device |
MX2019000888A (es) | 2016-07-22 | 2019-06-03 | Proteus Digital Health Inc | Percepcion y deteccion electromagnetica de marcadores de evento ingeribles. |
CN109963499B (zh) | 2016-10-26 | 2022-02-25 | 大冢制药株式会社 | 用于制造具有可吸收事件标记器的胶囊的方法 |
US11045142B1 (en) | 2017-04-29 | 2021-06-29 | Biolinq, Inc. | Heterogeneous integration of silicon-fabricated solid microneedle sensors and CMOS circuitry |
EP3506533B1 (en) | 2017-12-29 | 2022-03-30 | Nokia Technologies Oy | Sensing apparatus and system |
ES2974786T3 (es) | 2020-07-29 | 2024-07-01 | Biolinq Incorporated | Sistema de monitorización continua de analitos con matriz de microagujas |
US11857344B2 (en) | 2021-05-08 | 2024-01-02 | Biolinq Incorporated | Fault detection for microneedle array based continuous analyte monitoring device |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4615340A (en) * | 1985-02-27 | 1986-10-07 | Becton, Dickinson And Company | Sensor assembly suitable for blood gas analysis and the like and the method of use |
IL89159A0 (en) * | 1989-02-02 | 1989-09-10 | Optical Chemical Tech Oct | Medical probe |
ES2099182T3 (es) * | 1991-06-26 | 1997-05-16 | Ppg Industries Inc | Conjunto sensor electroquimico. |
AT397458B (de) * | 1992-09-25 | 1994-04-25 | Avl Verbrennungskraft Messtech | Sensoranordnung |
US5375604A (en) * | 1992-12-11 | 1994-12-27 | Siemens Medical Electronics, Inc. | Transportable modular patient monitor |
DE4329898A1 (de) * | 1993-09-04 | 1995-04-06 | Marcus Dr Besson | Kabelloses medizinisches Diagnose- und Überwachungsgerät |
US5474065A (en) * | 1994-04-04 | 1995-12-12 | Graphic Controls Corporation | Non-invasive fetal probe |
US6058321A (en) * | 1995-09-07 | 2000-05-02 | Swayze; Claude R. | Instrument for continuously monitoring fetal heart rate and intermittently monitoring fetal blood pH and method of use |
JPH10314149A (ja) * | 1997-05-20 | 1998-12-02 | Casio Comput Co Ltd | プローブが交換可能な電気測定器及びプローブ管理方法及びパルスオキシメータ |
GB9815667D0 (en) * | 1998-07-17 | 1998-09-16 | Medinnova Sf | Device |
US6264611B1 (en) * | 1998-11-25 | 2001-07-24 | Ball Semiconductor, Inc. | Monitor for interventional procedures |
JP4189787B2 (ja) * | 2001-03-06 | 2008-12-03 | 日本光電工業株式会社 | 生体情報表示モニタおよびそのシステム |
WO2002089663A1 (de) * | 2001-05-07 | 2002-11-14 | Cardiosafe International Ag | Anordnung zum überwachen eines patienten |
DE10141732A1 (de) * | 2001-08-25 | 2003-03-06 | Horst Frankenberger | Verfahren und Vorrichtung zur Langzeitbestimmung der Konzentration mindestens einer Substanz in einer Körperflüssigkeit |
US6616614B2 (en) * | 2001-09-18 | 2003-09-09 | Keimar Corporation | Apparatus and method for ascertaining cardiac output and other parameters |
US6879850B2 (en) * | 2002-08-16 | 2005-04-12 | Optical Sensors Incorporated | Pulse oximeter with motion detection |
US7539537B2 (en) * | 2002-10-03 | 2009-05-26 | Scott Laboratories, Inc. | Systems and methods for providing sensor fusion |
US20040138688A1 (en) * | 2002-10-09 | 2004-07-15 | Jean Pierre Giraud | Lancet system including test strips and cassettes for drawing and sampling bodily material |
-
2005
- 2005-09-08 AU AU2005281502A patent/AU2005281502A1/en not_active Abandoned
- 2005-09-08 CN CNA2005800298151A patent/CN101026996A/zh active Pending
- 2005-09-08 KR KR1020077005433A patent/KR20070052781A/ko not_active Application Discontinuation
- 2005-09-08 JP JP2007530764A patent/JP2008512162A/ja active Pending
- 2005-09-08 CA CA002578078A patent/CA2578078A1/en not_active Abandoned
- 2005-09-08 EP EP05778573A patent/EP1788933A1/en not_active Withdrawn
- 2005-09-08 BR BRPI0514953-3A patent/BRPI0514953A/pt not_active IP Right Cessation
- 2005-09-08 WO PCT/GB2005/003461 patent/WO2006027586A1/en active Application Filing
-
2007
- 2007-03-14 NO NO20071363A patent/NO20071363L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20070052781A (ko) | 2007-05-22 |
BRPI0514953A (pt) | 2008-07-01 |
AU2005281502A1 (en) | 2006-03-16 |
WO2006027586A1 (en) | 2006-03-16 |
NO20071363L (no) | 2007-06-06 |
JP2008512162A (ja) | 2008-04-24 |
CN101026996A (zh) | 2007-08-29 |
EP1788933A1 (en) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2578078A1 (en) | Sensor | |
US20080319278A1 (en) | Sensor | |
US7826880B2 (en) | Electrochemical sensor for in-vivo or ex-vivio measurements of the carbon dioxide partial pressure of living tissue | |
US8003401B2 (en) | Carbon dioxide sensor and method of determining partial pressure of carbon dioxide | |
JPH08512213A (ja) | 遠隔感知圧力測定カテーテル装置と方法 | |
US20230093510A1 (en) | Membrane sealing for a physiological sensor | |
WO2004058057A1 (en) | Sensor device for monitoring perfusion of tissue | |
Weil et al. | Patient CO2 measurement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |